The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis.
BACKGROUND
Systemic inflammatory parameters, such as the elevator PLR (platelet-lymphocyte ratio), the NLR (neutrophil-lymphocyte ratio) and the platelet count (PLT), have been found to be associated with the prognosis in gastric cancer; however, these results, especially those relating to the PLR, remain inconsistent. So we aimed to evaluate the prognostic role of the PLR in gastric cancer by conducting and presenting the findings of this meta-analysis.


METHODS
We conducted a systematic literature search in PubMed, Embase and the Cochrane Library to evaluate the prognostic value of the PLR in gastric cancer. The quality of the included studies was evaluated using the Newcastle Ottawa Quality Assessment Scale (NOS). The hazard ratio (HR) /Odds Ratio (OR) and its 95% confidence were pooled using a random effects model. A funnel plot based on overall survival was used to evaluate the publication bias.


RESULTS
It total, 8 studies comprising 4513 patients with gastric cancer met the pre-setting inclusion criteria. In comparison to the normal PLR, an elevated PLR was correlated with a higher risk of lymph node metastasis with an OR of 1.50 (95% Cl:1.24-1.82; I2 = 17%) and serosal invasion (T3 +T4) risk with an OR of 2.01 (95% Cl: 1.49-2.73; I2 = 55%), and an elevated PLR also increased the advanced stage (III +IV) risk with an OR of 1.99 (95% Cl: 1.60-2.46; I2 = 28%). An elevated PLR was not a reliable predictor for OS with an HR of 0.99 (95% CI: 0.9-1.1; I2 = 12%).


CONCLUSIONS
An elevated PLR was correlated with a higher risk of lymph node metastasis, serosal invasion and advanced stage (III +IV) risk in gastric cancer; however, the PLR may not act as a negative predictor for the overall survival of gastric cancer.
Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Zhengshui
Z
Xu
Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Wei
W
Xu
Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Hua
H
Cheng
Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Wei
W
Shen
Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Jiaqi
J
Ying
Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Fei
F
Cheng
Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Wenji
W
Xu
Int J Surg. 2015 Sep;21:84-91
26225826
Trials. 2007 Jun 07;8:16
17555582
Onco Targets Ther. 2015 Jun 17;8:1375-85
26124667
J Hepatol. 2012 Nov;57(5):1013-20
22732513
World J Gastroenterol. 2015 May 21;21(19):5961-71
26019461
Cell. 2010 Mar 19;140(6):883-99
20303878
PLoS One. 2014 Jun 26;9(6):e101119
24968121
Control Clin Trials. 1986 Sep;7(3):177-88
3802833
Carcinogenesis. 2015 Oct;36(10):1121-8
26130675
Hepatology. 2014 Sep;60(3):858-71
24443059
Transl Oncol. 2015 Aug;8(4):339-45
26310380
Tumour Biol. 2012 Jun;33(3):749-56
22198641
J Transl Med. 2015 Feb 18;13:66
25885254
J Thorac Oncol. 2012 Mar;7(3):587-94
22307011
Cell. 2011 Mar 4;144(5):646-74
21376230
Cancer Causes Control. 2009 Feb;20(1):15-26
18704713
J Thromb Haemost. 2011 Feb;9(2):237-49
21040448
PLoS Med. 2009 Jul 21;6(7):e1000100
19621070
Med Oncol. 2013 Mar;30(1):439
23307251
Colorectal Dis. 2012 Oct;14(10):e701-7
22731833
Am J Surg. 2012 Sep;204(3):294-9
22444831
Med Oncol. 2010 Dec;27(4):1060-5
19847679
Int J Clin Exp Med. 2015 Apr 15;8(4):5937-42
26131188
Biomarkers. 2014 Sep;19(6):444-51
24910346
Carcinogenesis. 2009 Jul;30(7):1073-81
19468060
Am J Surg. 2009 Apr;197(4):466-72
18639229
Cancer Res. 1999 Mar 15;59(6):1295-300
10096562
Eur J Gastroenterol Hepatol. 2016 May;28(5):493-502
26854795
Pharmacol Ther. 2016 Jan;157:112-9
26615781
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
26742998
Nature. 2008 Jul 24;454(7203):436-44
18650914
Cell. 2010 Apr 2;141(1):39-51
20371344
Ann Surg Oncol. 2015 Dec;22(13):4363-70
25805235
Eur J Epidemiol. 2010 Sep;25(9):603-5
20652370